HELP WITH POST MENOPAUSE
What is Post Menopause?
Symptoms, diagnosis and specialist care
Post-menopause: key points
- Post-menopause begins 12 months after the final menstrual period
- Symptoms may persist or develop for many years and do not always resolve on their own
- Long-term low oestrogen affects multiple systems, including bone, cardiovascular, and urogenital health
- HRT can be continued long term where benefits outweigh risks and may still be started later in life following individualised assessment
- Vaginal oestrogen is safe and effective for ongoing genitourinary symptoms
- New or unexpected bleeding after menopause should always be assessed
Post-menopause refers to the stage of life after menstrual periods have permanently stopped. While this phase is often described as the point at which menopausal symptoms settle, this is not always the case.
Many people continue to experience symptoms in post-menopause, and some develop new concerns several years later.
Post-menopause is associated with sustained low levels of oestrogen. This has ongoing effects across multiple systems in the body and can influence symptoms, long-term health, and treatment needs over time.
What does post-menopause mean?
You are considered post-menopausal once it has been 12 consecutive months since your final menstrual period, not due to other causes. From this point onwards, ovarian oestrogen production remains consistently low.
Unlike perimenopause, symptoms experienced in post-menopause are related to long-term oestrogen deficiency rather than hormonal fluctuation.
Symptoms in post-menopause
Symptoms in post-menopause vary widely. Some people notice improvement over time, while others continue to experience symptoms or develop new ones.
Common post-menopausal symptoms include:
- Hot flushes and night sweats
- Sleep disturbance
- Low mood or anxiety
- Cognitive symptoms such as brain fog or difficulty concentrating
- Fatigue
- Joint pain, stiffness, or reduced muscle strength
- Vaginal dryness, pain during sex, or urinary symptoms
- Reduced libido
- Changes in body composition, weight gain, or metabolic health
Symptoms do not always resolve spontaneously and can remain clinically significant many years after menopause.
Health considerations after menopause
The post-menopausal period is associated with changes in longer-term health risk, particularly in relation to:
- Bone density and osteoporosis
- Cardiovascular health
- Muscle mass and physical strength
- Metabolic health
This does not mean that everyone will develop health problems, but it highlights the importance of individualised assessment and informed discussion around prevention and treatment.
Bone health and lifestyle in post-menopause
After menopause, reduced oestrogen levels are associated with accelerated loss of bone density, increasing the risk of osteoporosis and fractures. Bone loss is most rapid in the early post-menopausal years but continues over time.
Assessment of bone health may include review of individual risk factors and, where appropriate, bone density scanning.
Lifestyle factors play an important role in supporting bone and musculoskeletal health in post-menopause. Evidence-based recommendations include:
- Regular weight-bearing and resistance exercise to support bone density, muscle strength, and balance
- Adequate calcium intake, preferably through diet,
- Ensuring adequate vitamin D intake, particularly in the UK, where deficiency is common
- Maintaining muscle strength to reduce falls risk
- Avoiding smoking and moderating alcohol intake
Hormone replacement therapy can help prevent bone loss and reduce fracture risk in post-menopausal women. NICE and British Menopause Society guidance recognise HRT as an effective option for osteoporosis prevention in appropriate individuals, particularly when started around the time of menopause. Other non-hormonal treatments may also be indicated depending on bone density and overall fracture risk.
HRT in post-menopause
Hormone replacement therapy remains an effective treatment option in post-menopause. Some people start HRT during perimenopause and continue long term, while others consider treatment for the first time after menopause.
There is no fixed duration for HRT use. NICE guidance supports continued treatment for as long as the benefits outweigh the risks for the individual, with regular review.
Reviewing HRT in post-menopause
Many people who have been using HRT for several years notice that it no longer feels as effective as it once did. This is a common reason for post-menopausal review.
Hormone requirements can change over time. Treatment started in perimenopause may not remain optimally matched to post-menopausal physiology. Changes in absorption, lifestyle and general health can also influence symptom control.
A structured review may include adjusting oestrogen dose, changing formulation or route, reviewing progesterone choice or dose, or considering the role of testosterone where appropriate. NICE and BMS recommend that HRT should be reviewed at least annually.
Starting HRT in post-menopause, including later in life
Some people consider HRT for the first time several years after menopause, including in their 60s and beyond. This can be appropriate in selected circumstances, particularly where symptoms remain significant and affect quality of life.
Starting HRT later requires careful individualised assessment. The balance of benefits and risks changes with age and time since menopause, particularly in relation to cardiovascular and thrombotic risk. Lower doses and transdermal oestrogen are often recommended when initiating treatment later in life.
Decisions should be based on symptoms, health profile, preferences, and current clinical guidance rather than age alone.
Bleeding after menopause
Any vaginal bleeding occurring more than 12 months after the final menstrual period is defined as post-menopausal bleeding and should always be assessed.
While many causes are benign, post-menopausal bleeding is considered abnormal until investigated. Possible causes include endometrial atrophy, polyps, fibroids, infection, or effects related to hormone therapy. Less commonly, it may be associated with endometrial hyperplasia or cancer.
Bleeding can occur when starting or changing HRT, particularly in the early months. However, new, persistent, or unexpected bleeding should be assessed in line with national guidance.
Genitourinary syndrome of menopause (GSM)
Genitourinary syndrome of menopause describes a collection of symptoms caused by the long-term effects of low oestrogen on the vulva, vagina, urethra, and bladder. GSM is common in post-menopause and tends to progress over time if untreated.
Symptoms may include vaginal dryness, irritation or burning, pain during sex, recurrent urinary tract infections, urinary urgency or frequency, and discomfort during pelvic examinations or smear tests.
There are a range of effective treatment options available, and management should be individualised.
These may include:
- Local vaginal oestrogen preparations such as creams, pessaries, tablets, or rings
- Vaginal moisturisers for regular use
- Vaginal lubricants to reduce discomfort during sex
- Non-hormonal treatments for those who cannot or choose not to use oestrogen
- Adjustment of systemic HRT where appropriate
Local vaginal oestrogen is the first-line treatment for GSM and is safe for long-term use. It can be used at any age, with or without systemic HRT.
Our approach to post-menopausal care
At Manchester Menopause Hive, post-menopausal care is:
- Individualised and evidence-based
- Guided by NICE and British Menopause Society recommendations
- Focused on symptom control, long-term health, and quality of life
- Delivered with time for assessment, explanation, and review
We offer both in-person and online consultations and support people at all stages of post-menopause.
Post-menopause FAQs
Should symptoms have resolved by post-menopause?
No. NICE and BMS recognise that menopausal symptoms may persist for many years after menopause, and new symptoms can develop in post-menopause.
Is there a maximum time you can stay on HRT?
There is no fixed upper time limit. HRT can be continued for as long as the benefits outweigh the risks, however an annual review is important.
Can HRT be started years after menopause?
Yes, in selected cases. Starting HRT later requires careful assessment of individual risks and benefits.
Do I still need progesterone after menopause?
No. GSM is a chronic condition related to oestrogen deficiency and usually requires treatment.
Does GSM improve on its own?
No. GSM is a chronic condition related to oestrogen deficiency and usually requires treatment.
Should I seek review if my HRT no longer feels effective?
Yes. Treatment needs can change over time, and an annual review is needed to ensure therapy remains appropriate.
POST MENOPAUSE SUPPORT
Book an appointment with one of our Post Menopause experts
At Manchester Menopause Hive, we have experience supporting women with post menopause and complex symptom presentations.
Our approach is evidence-based, individualised, and centred on listening to your experience. If this page has resonated with you, a specialist conversation can be a helpful next step.
